PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31330833-0	2019	ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib.	Sorafenib	107-116	angiopoietin 2	Homo sapiens	0-6	
33102759-13	2020	Responder rate was 40% (2/5) in patients with high baseline ANG2 and FGF19 levels who received sorafenib.	Sorafenib	95-104	angiopoietin 2	Homo sapiens	60-64	
21233403-10	2011	When combined with sunitinib, sorafenib, bevacizumab, irinotecan, or docetaxel, Ang2 CovX-Bodies produced even greater efficacy (~80% TGI, P < 0.01).	Sorafenib	30-39	angiopoietin 2	Homo sapiens	80-84	
31330833-8	2019	Our results suggest that ANGPT2rs55633437 and NOS3 rs2070744 polymorphisms could identify a subset of HCC patients more resistant to sorafenib.	Sorafenib	133-142	angiopoietin 2	Homo sapiens	25-31	
26420960-4	2015	Studies based on patient cohorts identified the potential of blood levels of angiopoietin-2, hepatocyte growth factor, insulin-like growth factor-1, and transforming growth factor-beta1 for predicting sorafenib efficacy.	Sorafenib	201-210	angiopoietin 2	Homo sapiens	77-91	
27266362-5	2016	In the (90)Y/sorafenib arm, Ang-2 and PDGF decreased at 2 weeks and the remainder increased.	Sorafenib	13-22	angiopoietin 2	Homo sapiens	28-33	
30402928-7	2019	CONCLUSIONS: Predictions of overall survival and post-progression survival were possible by periodically measuring serum proangiogenic cytokines, especially angiopoietin-2, in patients with HCC treated with sorafenib.	Sorafenib	207-216	angiopoietin 2	Homo sapiens	157-171	
24374901-7	2014	Repeated measures linear modeling from 15 patients demonstrated increased Ang2 (P <= 0.05) and decreased sVEGFR2 (P <= 0.05) after exposure to sorafenib.	Sorafenib	149-158	angiopoietin 2	Homo sapiens	74-78	
24045661-8	2013	CONCLUSION: High expression of Ang-2 or more than cytokines in serum is associated with poor PFS and OS in HCC patients treated with sorafenib.	Sorafenib	133-142	angiopoietin 2	Homo sapiens	31-36